News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioNeutral Announces Agreement With Nyco Products Company For Distribution Of A Ready To Use Sterilant To Long Term Care Markets



6/11/2014 9:17:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEWARK, NJ--(Marketwired - June 11, 2014) - BioNeutral Group, Inc. (PINKSHEETS: BONU) (OTC Pink: BONU) announced that it has entered into a Sales and Distribution Agreement with Nyco Products Company (Nyco) in Countryside, Illinois, to distribute BioNeutral's YGIENE™ 206 Sterilant for advanced infection control. Nyco is a respected manufacturer and distributor of cleaners, disinfectants and sanitizers for janitorial, hospitality, long term care, MRO, and food service. YGIENE™ 206 adds a superior level of infection control to Nyco's product offering in these markets.

BioNeutral's patent-pending YGIENE™ 206 is EPA registered and engineered to be a cleaner, disinfectant, and hospital grade sporacide/sterilant on hard, non-porous surfaces. Its rapid surface sterilization makes it particularly effective for hospital, medical, terminal, and long term care environments. YGIENE™ 206 kills most organisms in 90 to 120 seconds and all microbial life within 20 minutes of contact time. It is ideally suited for sterilizing surgical tables and non-invasive equipment, and for disinfecting and sterilizing areas where patients with infectious diseases have been treated.

The partnership between Nyco and BioNeutral will be advantageous for customers of both companies. YGIENE™ 206 brings additional efficacy in infection control to Nyco's product offering, while Nyco provides exceptional support in sales and customer training, plus critical exposure to a national distribution network for BioNeutral. According to Ray Dunning, Sr. Vice President of Sales for BioNeutral, "Nyco's ability to offer us direct and immediate national access to long term health care markets and other specialty channels is extremely attractive. Without question, Nyco is the type of company with whom we want to be associated. Their commitment to innovation in cleaning and disinfecting along with their industry leadership and longevity make them an ideal distributor partner for BioNeutral."

"We're very excited to team up with BioNeutral to be able to offer our customers amazing solutions that have the potential to reduce healthcare associated infections (HAIs) in hospitals and other healthcare facilities," stated Bob Stahurski, President and CEO of Nyco Products Company. "A one-step non-chlorine bleach alternative sterilant that kills all mircoorganisms within 20 minutes could highly impact disinfection procedures and protocols for the healthcare market. One key reason we chose to partner with BioNeutral is because YGIENE™ 206 does not have the adverse patient reactions associated with chlorine and bleach based products."

About Nyco Products Company

Nyco Products Company is a specialty manufacturer of high performance national cleaning brands and private branded chemicals used in the sanitary maintenance, healthcare, hospitality, food service, industrial, institutional and other cleaning markets. Founded in 1920, Nyco has a rich history of leadership and innovation in their industry, and is committed to delivering safe and healthy cleaning and disinfecting products with a high degree of efficacy. Nyco is a co-founding member of ChemBlend International LLC (CBI), a strategic alliance of specialty chemical blenders in North America. Visit www.nycoproducts.com for additional information on Nyco.

About BioNeutral Group, Inc.

Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is a specialty technology-based life-science company that has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, YGIENE™ and OGIENE™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the YGIENE™ brand have been approved by the EPA for sale in the United States. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutral.com.


CONTACTS:
FOR THE COMPANY:
Mark Lowenthal
CEO
BioNeutral Group, Inc.
+1-973-577-8003

Craig Fisher
S.T.A.T Group LLC
+1-786-375-0556



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES